US Bancorp DE Decreases Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

US Bancorp DE reduced its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 5.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 10,467 shares of the company’s stock after selling 624 shares during the period. US Bancorp DE’s holdings in Doximity were worth $456,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. LRI Investments LLC bought a new position in shares of Doximity in the first quarter worth approximately $27,000. Blue Trust Inc. boosted its position in shares of Doximity by 621.4% in the second quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock worth $37,000 after purchasing an additional 1,193 shares during the period. Quarry LP boosted its position in shares of Doximity by 101.2% in the second quarter. Quarry LP now owns 1,616 shares of the company’s stock worth $45,000 after purchasing an additional 131,253 shares during the period. DekaBank Deutsche Girozentrale bought a new position in shares of Doximity in the first quarter worth approximately $46,000. Finally, First Horizon Advisors Inc. boosted its position in shares of Doximity by 80.0% in the second quarter. First Horizon Advisors Inc. now owns 1,710 shares of the company’s stock worth $48,000 after purchasing an additional 760 shares during the period. 87.19% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

DOCS has been the subject of a number of recent analyst reports. Raymond James reiterated an “outperform” rating and issued a $65.00 price target (up from $37.00) on shares of Doximity in a research report on Friday. JPMorgan Chase & Co. upped their target price on shares of Doximity from $27.00 to $30.00 and gave the stock a “neutral” rating in a research report on Monday, August 19th. Canaccord Genuity Group upped their target price on shares of Doximity from $37.00 to $40.00 and gave the stock a “buy” rating in a research report on Tuesday, August 20th. KeyCorp upgraded shares of Doximity from a “sector weight” rating to an “overweight” rating and set a $70.00 target price for the company in a research report on Friday. Finally, Truist Financial restated a “hold” rating and set a $35.00 target price (up previously from $31.00) on shares of Doximity in a research report on Wednesday, August 14th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $45.69.

Doximity Price Performance

DOCS stock opened at $61.25 on Tuesday. The company has a market capitalization of $11.37 billion, a PE ratio of 70.40, a P/E/G ratio of 7.00 and a beta of 1.30. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $61.75. The firm’s 50-day moving average is $42.04 and its 200 day moving average is $33.44.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.